Enanta Pharmaceuticals (ENTA) Property, Plant & Equipment (Net) Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.92% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -11.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.87% |
| Dec 31, 2025 | -8.19% |
| Sep 30, 2025 | 8.28% |
| Jun 30, 2025 | 46.17% |
| Mar 31, 2025 | 142.73% |
| Dec 31, 2024 | 208.34% |
| Sep 30, 2024 | 174.25% |
| Jun 30, 2024 | 108.52% |
| Mar 31, 2024 | 40.08% |
| Dec 31, 2023 | 39.59% |
| Sep 30, 2023 | 93.08% |
| Jun 30, 2023 | 161.86% |
| Mar 31, 2023 | 129.49% |
| Dec 31, 2022 | 59.74% |
| Sep 30, 2022 | 3.87% |
| Jun 30, 2022 | -30.62% |
| Mar 31, 2022 | -31.59% |
| Dec 31, 2021 | -30.21% |
| Sep 30, 2021 | -30.86% |
| Jun 30, 2021 | -28.78% |
| Mar 31, 2021 | -27.73% |
| Dec 31, 2020 | -25.17% |
| Sep 30, 2020 | -21.33% |
| Jun 30, 2020 | -18.36% |
| Mar 31, 2020 | -15.14% |
| Dec 31, 2019 | 9.63% |
| Sep 30, 2019 | 30.49% |
| Jun 30, 2019 | 35.67% |
| Mar 31, 2019 | 33.19% |
| Dec 31, 2018 | 20.62% |
| Sep 30, 2018 | 4.04% |
| Jun 30, 2018 | 3.88% |
| Mar 31, 2018 | 1.06% |
| Dec 31, 2017 | -5.25% |
| Sep 30, 2017 | 0.56% |
| Jun 30, 2017 | 7.61% |
| Mar 31, 2017 | 10.86% |
| Dec 31, 2016 | 5.51% |
| Sep 30, 2016 | 35.98% |
| Jun 30, 2016 | 190.43% |
| Mar 31, 2016 | 235.12% |
| Dec 31, 2015 | 309.57% |
| Sep 30, 2015 | 226.46% |
| Jun 30, 2015 | 66.47% |
| Mar 31, 2015 | 66.67% |
| Dec 31, 2014 | 78.46% |
| Sep 30, 2014 | 60.84% |
| Jun 30, 2014 | 34.64% |
| Mar 31, 2014 | 57.19% |
| Sep 30, 2013 | 83.47% |